Cancer Research Research Funding  Folkman
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 21, 790-, July 1, 1961]
© 1961 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haran-Ghera, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haran-Ghera, N.

The Role of Mammotrophin in Mammary Tumor Induction in Mice*

Nechama Haran-Ghera

( Department of Experimental Biology, The Weizmann Institute of Science, Rehovoth, Israel)

Untreated LAF1 mice used in the present series (which are generally considered to be free of the mammary tumor agent) did not develop mammary adenocarcinomas spontaneously. Treatment with methylcholanthrene also failed to produce mammary tumors in this strain in the absence of hormonal stimulation of the mammary tissue (though it did produce leukemia and squamous carcinomas). Continuous stimulation of the mammary gland by the mammotrophic stimulating hormone produced mammary tumors in about 9 per cent of mice, with lung metastases in some cases. Methylcholanthrene, when applied on nonstimulated normal breast tissue, followed by mammotrophic hormone stimulation as a possible promoter, did not increase the percentage of mammary tumors above the control level. Methylcholanthrene did increase the mammary tumor incidence to 35 per cent in the case when the mammary glands were previously stimulated by mammotrophin hormone for 5 weeks, with simultaneous action of methylcholanthrene plus the mammotrophin hormone for 1 subsequent weeks. Mammary gland stimulation for 6 months, followed by methylcholanthrene paintings alone, elicited only a moderate increase in mammary tumor incidence (16.6 per cent). Whether the function of mammotrophin in mice is mainly to induce hyperplastic nodules, necessary as a primary stage of mammary tumor development, or whether it serves also as a promoting agent in mammary tumor development, requires further elaboration. The mammotrophic pituitary tumor used in these experiments, as a natural source of mammotrophin, exhibited somatotrophic activity and also a possible luteotrophic action.

* This work was supported in part by Grant DRG 493A from the Damon Runyon Memorial Fund for Cancer Research.

Received 1/26/61.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1961 by the American Association for Cancer Research.